NAI reports HY 2025 private label contract manufacturing sales of USD 68.87 million, up 9 percent

Reuters
02/14
NAI reports HY 2025 private label contract manufacturing sales of USD 68.87 million, up 9 percent

NAI - Natural Alternatives International Inc. released its earnings for the quarter and half year ended December 31, 2025. The company reported net cash used in operating activities of USD 10.4 million for the half year $(HY)$ ended December 31, 2025. This compares to net cash used in operating activities of USD 3.4 million for the same period in the prior year, with the increase primarily attributed to higher foreign currency exchange losses and increased cash used by changes in accounts receivable, which amounted to USD 3.1 million for the period. The provision for income taxes for the three-month (Q2) period ended December 31, 2025, was an expense of approximately USD 0.2 million, compared to a benefit of approximately USD 0.7 million for the same period in 2024. For the six-month (HY) period ended December 31, 2025, the provision for income taxes was USD 0.3 million, compared to a tax benefit of USD 1.1 million in the prior year. The increase was primarily due to a 5 Swiss withholding tax on a dividend paid by its Swiss subsidiary NAIE to NAI, as well as income before income taxes from NAIE. NAI's primary business remains the provision of private-label contract manufacturing services for companies marketing and distributing vitamins, minerals, herbal, and other nutritional supplements. The company’s revenue continues to rely heavily on sales to a small number of private-label contract manufacturing customers, and results are subject to variations in order timing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NAI - Natural Alternatives International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-004118), on February 13, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10